Herpes Research Today is a free monthly online journal that collates and summarizes the latest research about Herpes, including details on herpes simplex virus (hsv), genital, oral, symptoms, treatment.

Volume 3 (2006), Issue 7 (July)

1. Maternal herpes simplex virus antibody avidity and risk of neonatal herpes.
   Am J Obstet Gynecol, 195(1): 115-20. [Abstract] [Full-text]
2. Caspase 3 activation during herpes simplex virus 1 infection.
   Virus Res, 120(1): 163-75. [Abstract] [Full-text]
3. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript.
   Nature, 442(7098): 82-5. [Abstract] [Full-text]
4. Engineering of a single conserved amino acid residue of herpes simplex virus type 1 thymidine kinase allows a predominant shift from pyrimidine to purine nucleoside phosphorylation.
   J Biol Chem, 281(28): 19273-9. [Abstract] [Full-text]
5. Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection.
   Virus Res, 121(1): 1-10. [Abstract] [Full-text]
6. Crystal structure of glycoprotein B from herpes simplex virus 1.
   Science, 313(5784): 217-20. [Abstract] [Full-text]
7. Herpes simplex virus 1 precludes replenishment of the short-lived receptor of tumor necrosis factor alpha by virion host shutoff-dependent degradation of its mRNA.
   J Virol, 80(15): 7756-9. [Abstract] [Full-text]
8. Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response.
   J Virol, 80(15): 7600-12. [Abstract] [Full-text]
9. Resistance of mRNA translation to acute endoplasmic reticulum stress-inducing agents in herpes simplex virus type 1-infected cells requires multiple virus-encoded functions.
   J Virol, 80(15): 7354-63. [Abstract] [Full-text]
10. Serial passage through human glioma xenografts selects for a Deltagamma134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors.
    J Virol, 80(15): 7308-15. [Abstract] [Full-text]
11. Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.
    J Infect Dis, 194(4): 420-7. [Abstract] [Full-text]
12. Enhancement of antitumor activity of herpes simplex virus gamma(1)34.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide.
    Cancer Gene Ther, 13(8): 780-91. [Abstract] [Full-text]

© 2004-2008 Herpes Research Today. All Rights Reserved.